National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Hypercalcemia (PDQ®)
Patient Version   Health Professional Version   En español   Last Modified: 12/08/2008



Introduction






Overview






Causes






Incidence






Symptoms






Assessment






Treatment






Get More Information From NCI






Changes to This Summary (12/08/2008)






Questions or Comments About This Summary






About PDQ



Page Options
Print This Page
Print Entire Document
View Entire Document
E-Mail This Document
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
Quit Smoking Today
NCI Highlights
Report to Nation Finds Declines in Cancer Incidence, Death Rates

High Dose Chemotherapy Prolongs Survival for Leukemia

Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E

The Nation's Investment in Cancer Research FY 2009

Past Highlights
Introduction

This patient summary on hypercalcemia is adapted from the PDQ summary written for health professionals by cancer experts. This and other credible information about cancer treatment, screening, prevention, supportive care, and ongoing clinical trials is available from the National Cancer Institute. Hypercalcemia is a disorder in which the level of calcium in the blood is too high. Hypercalcemia is the most common life-threatening disorder associated with cancer. This brief summary describes hypercalcemia, its causes and treatment.

Back to Top

Next Section >


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov